NuQ®

March 11, 2016May 13, 2016

For Idiopathic Pulmonary Fibrosis, NuQ Blood Test a Promising Diagnostic Tool

VolitionRx, dedicated to the development of blood-based diagnostic tests, recently announced preliminary data from a pilot study showing that its blood test NuQ successfully detected 86 percent of patients with ... Read more

December 19, 2014December 19, 2014

Study To Confirm NuQ® Test Accuracy In Lung Cancer Is Being Initiated

Lung Cancer, News

VolitionRx Limited announced that University Hospital Bonn in Germany is initiating a confirmatory study to evaluate the Nucleosomics® platform, VolitionRx’s novel technological platform for the diagnosis of lung cancer that utilizes an individualized blood ... Read more

November 1, 2014December 1, 2014

VolitionRx Presents Positive Data From Pilot Lung Cancer Study

Lung Cancer, News

Last week, VolitionRx Limited presented the results of their pilot lung cancer study at the Science for Business BioWin Day 2014 in Louvain-la-Neuve, Belgium. The BioWin Day conference takes place every two years and is ... Read more